Yao Zhan
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
UV irradiation drives lineage-specific MITF-mediated transcription of PD-L1 to confer immune tolerance to UV-mutated melanocytes.
Journal: Immunity
Published: September 03, 2026
Corrigendum to 'The Role of eIF4E in Response and Acquired Resistance to Vemurafenib in Melanoma': [Journal of Investigative Dermatology, Volume 135, Issue 5, May 2015, Pages 1368-1376].
Journal: The Journal of investigative dermatology
Published: March 13, 2026
Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.
Journal: The Journal of clinical investigation
Published: May 01, 2024
Correction: MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ.
Journal: Cancer research
Published: April 15, 2024
MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma.
Journal: The Journal of clinical investigation
Published: April 15, 2024
A prospective pilot study of narrowband UV-B treatment of lichen planopilaris.
Journal: Journal of the American Academy of Dermatology
Published: December 15, 2021
The MNK1/2-eIF4E Axis Supports Immune Suppression and Metastasis in Postpartum Breast Cancer.
Journal: Cancer research
Published: September 15, 2020
Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.
Journal: The Journal of clinical investigation
Published: May 28, 2020
MNK1 signaling induces an ANGPTL4-mediated gene signature to drive melanoma progression.
Journal: Oncogene
Published: June 16, 2019
Gain-of-Function Genetic Alterations of G9a Drive Oncogenesis.
Journal: Cancer discovery
Published: May 07, 2019
MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ.
Journal: Cancer research
Published: May 24, 2018
Last Updated: 09/26/2026